News
Indian cancer care struggles with pandemic of late diagnoses and delayed treatments
An average cancer patient in India usually seeks treatment three months after the symptoms appear. Due to lack of transport facilities and fear of contracting coronavirus, the time to seek care during the COVID-19 pandemic has doubled, with patients finally…
Updated MINDACT results reveal chemotherapy benefit in some breast cancers varies by age
Updated results of the MINDACT trial confirm that women with early-stage breast cancer, who were assessed to be at high clinical but low genomic risk for recurrence, and did not receive chemotherapy, continue to have excellent distant metastasis free survival…
HPV vaccine “lying around” unused in Africa due to pandemic disruption
Vaccinations for human papillomavirus (HPV) in Africa are well below World Health Organisation (WHO) targets due to COVID-19 pandemic disruptions. The WHO Africa region target was to have 35 countries introduce the HPV vaccine by 2020, but only 16 countries…
Cancer caused by occupational exposure needs urgent attention
What is the cancer burden associated with occupational exposure? A new review shows that the question needs urgent attention, given under-reporting and current difficulties in estimating the global burden. The review, in Molecular Oncology, highlights how millions of workers are…
European vision for universal access to oncology precision medicine biomarker tests
Current access to high quality oncology biomarker testing across Europe is inconsistent and contributes to health inequalities. To address barriers to biomarker testing, the ‘Unlocking the potential of precision medicine in Europe’ report (published February 23 2021) proposes 12 policy…
EC probe sets precedent for cancer drug price reduction
The European Commission (EC) has made commitments offered by Aspen Pharmacare Holding, to reduce prices for six critical cancer medicines by around two thirds, legally binding. In the acceptance agreement (10 February) Aspen will additionally retrospectively reimburse member states by…
Study brings mass biparametric MRI screening for prostate cancer a step closer
Using biparametric (bp) magnetic resonance imaging (MRI) to screen for prostate cancer identified twice as many clinically significant cancers as standard prostate-specific antigen (PSA) tests. Moreover, the UK study, reported in JAMA Oncology (11 February), found bpMRI improved detection of…
Oncology providers urged to offer healthy life style advice to breast cancer survivors
Breast cancer survivors commonly experience treatment-related factors, such as fatigue, depression and discomfort, presenting barriers to the adoption of healthy life styles. The US questionnaire study, published in the Journal of the Academy of Nutrition and Dietetics (1 February 2021),…
Studies provide clarity on breast cancer genes for genetic panels
Two large case control studies have defined eight genes considered useful to include on genetic panels for predicting risk of breast cancer. The two studies, one by The Breast Cancer Association Consortium (BCAC), led by Doug Easton in Cambridge, and…
EC publishes route map for tackling cancer
A plan from the European Commission provides a roadmap for Europe to tackle the entire cancer pathway from prevention to improving the quality of life for cancer survivors. The aim of the Europe’s Beating Cancer Plan (published 3 February), accompanied…